Dr. Michael Esposito Montazeri, MD

Dr. Montazeri practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Montazeri's NPI, 1538115258, was assigned on May 25, 2006. Dr. Montazeri graduated from University of Toledo College of Medicine and Life Sciences in 2003. Dr. Montazeri holds California license A90721.

Dr. Montazeri's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Montazeri's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Montazeri is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Montazeri practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Montazeri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Montazeri is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dr. Montazeri is licensed in California.

Dmand AI lists adjustment disease, bile duct problems, electrolyte disorders, fibromyalgia and chronic pain, gastrointestinal bleeding, gastrointestinal inflammation, insomnia and irritable bowel syndrome (IBS) among the conditions Dr. Montazeri treats.

CMS data shows 524 Medicare services from Dr. Montazeri across 9 procedure codes in 2024, for 184 Medicare patients. Medicare paid $40,650 for them.

CMS counts 184 Medicare patients who saw Dr. Montazeri in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 43% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Montazeri's median patient age at 65, with 50% women.

In 2024, Dr. Montazeri wrote 409 Medicare Part D claims for 96 patients. 84% of them were for generic drugs. CMS names the drug for 103 of them, across 5 drugs with 11 or more claims each, at $2,803 in total drug cost. In 2023, CMS named 108 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Montazeri for performance year 2024, reported as part of a group. Dr. Montazeri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Montazeri. Dr. Montazeri's most frequent co-author is Ian Harold Jenkins, MD.

Dr. Montazeri graduated from University of Toledo College of Medicine and Life Sciences in 2003. Dr. Montazeri is a member of AAHPM and SHM.

Dr. Montazeri is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.